About Us

About ProtForge

Technology and science to accelerate therapeutic discovery

ProtForge is a biotechnological platform focused on the development of antibodies by artificial intelligence. Our approach integrates data science and computational biology to improve the affinity, specificity and stability of antibodies, facilitating the creation of more effective and personalized therapies.

  • Predictive models that improve the quality of antibodies.

  • Optimization of the R & D process to minimize resources.

  • We significantly agree on the research times.

0+
Optimized projects
0%
Precision in predictive models
0M +
Data analysed
0%
Saving in development time

Vision

IA and biotechnology to redesign drug development

ProtForge applies advanced artificial intelligence to the design of antibodies in order to transform the development of medicines: faster, more accurate and with lower error rate.

Our approach combines computational biology, machine learning and experimental validation to accelerate the creation of therapies for high-impact diseases such as cancer, infections, or immune pathologies.

We do not seek to find a solution among millions of options, but to design it directly from the structure of the disease

How we work

An approach based on artificial intelligence and scientific validation

At ProtForge we combine advanced artificial intelligence with computer biology principles to design antibodies more accurately and efficiently. Our process integrates data analysis, molecular modeling and experimental validation to reduce times and increase the probability of success.

1.
Molecular analysis

We study complex biological structures to identify therapeutic objectives with clinical potential.

2.
Artificial intelligence models

We apply machine learning to predict molecular interactions and optimize antibody design.

3.
Antibody design

We generate optimized candidates with greater affinity, stability and specificity.

4.
Experimental validation

We contract the results in laboratory environments to ensure their biological viability.

Scientific validation

Research based on experimental evidence and preclinical development

ProtForge's work is not limited to computer simulation. All our models are subject to laboratory validation in collaboration with research teams and academic environments specialized in biotechnology.

The company is currently working with pre-clinical antibodies, assessing their effectiveness, stability and therapeutic potential in high-clinical impact diseases.

The combination of artificial intelligence and experimental validation allows us to accelerate the discovery of therapies without compromising scientific rigour.

Contact

Let's talk about collaboration or projects

If you want more information about ProtForge, collaborate in research or explore applications of our technology, you can contact us directly. We answer all the professional questions.

ProtForge Limited Society

Avenida de Aragón 29, gate 5
46010 Valencia, Spain

Email

g.llopis22@gmail.com

Telephone

636 873 210